WO2003037358A1 - A pharmaceutical composition having cholagogic and litholytic effect and its preparation method - Google Patents

A pharmaceutical composition having cholagogic and litholytic effect and its preparation method Download PDF

Info

Publication number
WO2003037358A1
WO2003037358A1 PCT/CN2002/000622 CN0200622W WO03037358A1 WO 2003037358 A1 WO2003037358 A1 WO 2003037358A1 CN 0200622 W CN0200622 W CN 0200622W WO 03037358 A1 WO03037358 A1 WO 03037358A1
Authority
WO
WIPO (PCT)
Prior art keywords
present
pharmaceutical composition
cholagogic
preparation
quality control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2002/000622
Other languages
English (en)
French (fr)
Chinese (zh)
Inventor
Wei Xiao
Yin Yang
Ya Ling
Minghui Li
Zhenggen Liao
Chenfeng Zhang
Shubo Cao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Kanion Pharmaceutical Co Ltd
Original Assignee
Jiangsu Kanion Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Kanion Pharmaceutical Co Ltd filed Critical Jiangsu Kanion Pharmaceutical Co Ltd
Priority to US10/494,143 priority Critical patent/US20050042308A1/en
Priority to JP2003539701A priority patent/JP4593918B2/ja
Publication of WO2003037358A1 publication Critical patent/WO2003037358A1/zh
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PCT/CN2002/000622 2001-10-29 2002-09-05 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method Ceased WO2003037358A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/494,143 US20050042308A1 (en) 2001-10-29 2002-09-05 Pharmaceutical composition having cholagogic and litholytic effect and its preparation method
JP2003539701A JP4593918B2 (ja) 2001-10-29 2002-09-05 胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN01134090.8 2001-10-29
CNB011340908A CN1179735C (zh) 2001-10-29 2001-10-29 一种治疗肝胆结石的溶石性药物及制备方法

Publications (1)

Publication Number Publication Date
WO2003037358A1 true WO2003037358A1 (en) 2003-05-08

Family

ID=4672224

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2002/000622 Ceased WO2003037358A1 (en) 2001-10-29 2002-09-05 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method

Country Status (4)

Country Link
US (1) US20050042308A1 (cg-RX-API-DMAC7.html)
JP (1) JP4593918B2 (cg-RX-API-DMAC7.html)
CN (1) CN1179735C (cg-RX-API-DMAC7.html)
WO (1) WO2003037358A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210742B (zh) * 2010-04-09 2013-06-05 四川济生堂药业有限公司 薄荷素油在制备治疗胆汁淤积性肝病的药物中的应用
CN112516213B (zh) * 2020-12-30 2022-06-17 广西中医药大学 一种治疗胆结石的瑶药组合物、汤剂、胶囊剂及其应用
CN113421620B (zh) * 2021-05-17 2025-04-29 陕西中医药大学 基于uplc-q-tof/mse和整合效应的bp神经网络关联分析对中药不同功效的生物活性成分进行模糊识别的方法
CN113624707B (zh) * 2021-09-17 2024-06-18 云南博瑞生物科技有限公司 一种萝卜红气味定量检测方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060964A (zh) * 1990-10-29 1992-05-13 洛洪程 一种热伤药物的制取方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60172925A (ja) * 1984-02-17 1985-09-06 Kao Corp 胆石溶解剤
JPH0757734B2 (ja) * 1990-10-09 1995-06-21 呉羽化学工業株式会社 鎮静用香料組成物および香粧品
DE4330664A1 (de) * 1993-09-10 1995-03-16 Beiersdorf Ag Verwendungen von Pflanzenölen
JPH07242536A (ja) * 1994-03-01 1995-09-19 Toyo Capsule Kk 皮膜に精油成分が含有されたゼラチンカプセル剤
JP3828163B2 (ja) * 1994-06-10 2006-10-04 サンスター株式会社 抗炎症、抗かゆみ剤
EP0842604A1 (en) * 1996-11-13 1998-05-20 The Procter & Gamble Company Sprayable disinfecting compositions and processes for disinfecting surfaces therewith
IL129102A0 (en) * 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
EP1146112A1 (en) * 2000-04-14 2001-10-17 The Procter & Gamble Company Process of cleaning and/or disinfecting a hard surface with a composition comprising a biguanide antimicrobial agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060964A (zh) * 1990-10-29 1992-05-13 洛洪程 一种热伤药物的制取方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LI XINREN ET AL.: "Inhibitory effect of the oil distilled from pelargonium graveolens L' herit on aldrin-induced overgrowth of lens of chicken embyoeye", CANCER, vol. 13, no. 3, 1994, pages 203 - 205 *

Also Published As

Publication number Publication date
JP4593918B2 (ja) 2010-12-08
CN1358530A (zh) 2002-07-17
CN1179735C (zh) 2004-12-15
US20050042308A1 (en) 2005-02-24
JP2005514343A (ja) 2005-05-19

Similar Documents

Publication Publication Date Title
TWI271198B (en) Tables disintegrating rapidly in the oral cavity
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
WO2004016244A3 (en) Pharmaceutical compositions for buccal delivery of pain relief medications
WO2002058698A3 (en) Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
WO2002017855A3 (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
SG155046A1 (en) Process for modifying drug crystal formation
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
WO2001080619A3 (en) Pharmaceutical composition containing citalopram
WO2001097805A3 (en) Solid valsartan pharmaceutical compositions
WO2007134158A3 (en) Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
CA2467676A1 (en) Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
MY137846A (en) Processes for the preparation of oral dosage formulations of modafinil
WO2005107721A3 (en) Pharmaceutical dosage form comprising pellets as well as its manufacturing process
KR910005854A (ko) 캡슐 경구 투여 단위 형태의 구형 과립으로부터 조절된 방출 탄산 탈수 효소 저해제를 함유하는 제약학적 조성물 및 그 제조방법
WO2002060435A8 (fr) Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer
CA2483002A1 (en) New pharmaceutical composition
WO2004087880A3 (en) Compounds and their use to treat diabetes and related disorders
TW202038920A (zh) 發泡性經口固形製劑
AU2366501A (en) Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases
CA2166460A1 (en) Neomorphic ibuprofen and methods of using same
MD2722B2 (ro) Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei
EP2101742B8 (en) Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form
WO2004078108A3 (fr) Comprime de fenofibrate et procede de fabrication
JP6771274B2 (ja) 内服用組成物
EP4438121A3 (en) Pharmaceutical composition containing acetominophen and ibuprofen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003539701

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 10494143

Country of ref document: US

122 Ep: pct application non-entry in european phase